The Channel Group
The Channel Group (“TCG”) is a venture management and corporate advisory business focusing on the global life sciences industry. Each of the Managing Partners of TCG has amassed several decades of experience in the formation, management, and growth of companies in this sector. As serial entrepreneurs in their own right, TCG’s partners bring hands-on knowledge and experience and a significant collegial base to support the growth of client companies. TCG’s partners have been involved in numerous strategic partnering and licensing deals, a wide range of financings, mergers, acquisitions, and sales of companies and corporate divisions at a global level.
The Channel Group’s foundation has been built on the unique blend of its partners experience in academic research, Fortune 500 corporate management, and entrepreneurial management. Allan Goldberg, Ph.D., spent the formative years of his career at The Rockefeller University as professor of Virology. He was a co-founder of Innovir Laboratories, a multinational biotechnology company that focused on the development of RNA-based drugs. Upon the sale of Innovir, Dr. Goldberg focused his activities on the formation of several life sciences companies. Robert J. Beckman served as a Vice President at Revlon Health Care where he was responsible for strategic and marketing support in its pharmaceutical business. He went on to serve as Vice President and General Manager of a division of companies within Revlon. He engineered a management buyout that resulted in the genesis of Intergen Company. Intergen was a multinational life sciences company with strategic business units in pharmaceutical discovery tools, diagnostics, and biopharmaceutical manufacturing. The company was sold at the end of 2001.
The Channel Group Partners have been instrumental in the formation of a number of industry associations including BIO, The New York Biotechnology Association, and Council for Biomedical Research and have served as advisors to local and national politicians, United Sates and international governments, large pharmaceutical companies and biotechnology businesses of all sizes.
TCG and its colleagues support the development of new entrepreneurial life science companies as well as existing businesses within this sector. In start-up or early- stage ventures the team often serves as interim founding management, bringing the company to a point of critical mass with sufficient capital to attract world-class management. TCG’s activities within existing companies also might include business development, global representation, strategic alliance formation, capital formation, regulatory planning, development planning, academic and industry collaboration, and scientific and corporate board formation. TCG can work with venture capitalists to support their portfolio companies or can be directly engaged by companies.
© Ferskos LLC. Terms of Use
.